Time In Range

Adults with insulin-treated type 2 diabetes had a significant HbA1c decline at 13 weeks with use of the Omnipod 5 automated insulin delivery system, according to findings from the SECURE-T2D trial.

In patients with basal insulin-treated type 2 diabetes, sotagliflozin was associated with greater time in range compared with placebo at 18 weeks, researchers reported at the European Association for the Study of Diabetes Annual Meeting.

Adults with diabetes who use a smart pen for both basal and bolus insulin delivery have a reduction in time in range with each injection they miss over a 14-day period, according to data published in Diabetes Care.

Pregnant women with type 1 diabetes achieved a higher time in range and had fewer complications with use of a hybrid closed-loop insulin delivery system compared with continuous glucose monitoring alone, according to a speaker.

Among pregnant women with type 1 diabetes, more time in optimal glucose range at 12 weeks gestation was associated with lower risks for preeclampsia and large for gestational age infants, researchers reported.

Providers can use continuous glucose monitoring metrics as well as HbA1c to assess diabetic retinopathy risk for adults with type 1 diabetes, according to findings published in Diabetes Technology & Therapeutics.

The new continuous glucose monitoring metric Glycemia Risk Index better assesses hypoglycemia risk than time in range, according to study data.

Children and adolescents with type 1 diabetes had an increase in time in range and reduction in HbA1c after starting a tubeless hybrid closed-loop insulin delivery system, according to study data

Hybrid closed-loop insulin delivery can increase time in range for pregnant women with type 1 diabetes with no safety concerns, according to trial findings presented at the European Association for the Study of Diabetes annual meeting.

CHICAGO — Children with type 1 diabetes using closed-loop insulin delivery systems spend more time in range than those receiving insulin injections or using a sensor-augmented pump or continuous glucose monitor, according to study data.